Observation of Treatment Patterns With Lucentis in Approved Indications

Clinical trial NCT02194803 · COMPLETED

Trial details

NCT number: NCT02194803
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Neovascular AMD, Visual Impairment Due to DME, Visual Impairment Due to Macular Oedema Secondary to Branch or Central RVO, Visual Impairment Due to CNV

Start date: 2011-12-08
Primary completion: 2016-12-31
Enrollment: 5778

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.